Cellular rejuvenation is changing the way we think about aging. Some companies are now exploring treatments that claim to "reverse" the aging process at the cellular level. These technologies are still in their early stages, and while they offer exciting possibilities, it's important to consider the potential risks they may bring. One major breakthrough in this field happened in 2006, when Japanese researcher Shinya Yamanaka and his team discovered that by activating four specific proteins—OCT4, SOX2, KLF4, and c-MYC—in mice, they could essentially reset adult cells to a state similar to embryonic stem cells. This process, known as cellular reprogramming, opened the door to new medical possibilities, such as the potential to regenerate human tissues or even reverse some aspects of aging. However, there are challenges. A completely reprogrammed cell loses its identity—turning a neuron into a stem cell would make it no longer a neuron. If reprogramming were applied too broadly in the body, it could lead to serious issues, such as the formation of tumors or other abnormalities. This has led scientists to explore partial reprogramming, where only certain aspects of a cell are rejuvenated, allowing it to function more like a younger cell without losing its identity. For example, in tests on mouse retinal ganglion cells, scientists were able to restore some youthful functions to aging cells while maintaining their original role. This approach is now being considered for human applications. The first clinical applications of this technology are just beginning to take shape. Twenty years after Yamanaka's discovery, companies like YouthBio Therapeutics are developing experimental treatments, such as YB002, a gene therapy aimed at treating Alzheimer's disease. While the U.S. Food and Drug Administration (FDA) has given a positive response to the project, no human trials have started yet. Meanwhile, researchers and philosophers are also reflecting on the broader implications of these advancements. For instance, Edgar Morin, a philosopher and sociologist who recently turned 100, has expressed confidence in the safety of messenger RNA vaccines and has long been interested in the field of epigenetics, which studies how genes are expressed without altering the DNA itself. As science continues to push the boundaries of what is possible, questions about the ethical and practical consequences of these technologies are becoming more urgent. Researchers like Baptiste Morizot, a philosopher and biologist, have been following developments in medical fields such as organ transplantation, while others, like Camille Peugny, a sociologist, are examining how these scientific advances might reshape our political and philosophical views. Meanwhile, popular culture, such as the series Squid Game, has sparked discussions about the influence of media on children, raising concerns about the impact of violent imagery on young audiences. As we stand at the threshold of a new era in medicine and biology, the conversation about the future of human aging and health is only just beginning.